Nephrotic syndrome in syngeneic hematopoietic stem cell transplantation recipients: A case report

doi:10.12998/wjcc.v9.i3.614

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4350)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-6) series, Tables (1-1) series.

Item

Count

PDF

307

WORD

121

HTML

1958

Figures (1-6)

425

Tables (1-1)

372

Sum=3183

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

335

Download

832

Sum=1167

Jan 26, 2021 (publication date) through Feb 21, 2025

Times Cited of This Article

Times Cited (3)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Clin Cases. Jan 26, 2021; 9(3): 614-622
Published online Jan 26, 2021. doi: 10.12998/wjcc.v9.i3.614

Full Size Figure Download Figure

Figure 1 Specific medication scheme for syngeneic hematopoietic stem cell transplantation. ATG: Antithymocyte globulin; CTX: Cyclophosphamide; MTX: Methotrexate; VP-16: Etoposide; VPA: Valproate sodium.

Citation: Bai MC, Wu JJ, Miao KR, Zhu JF, Mao HJ. Nephrotic syndrome in syngeneic hematopoietic stem cell transplantation recipients: A case report. World J Clin Cases 2021; 9(3): 614-622
URL: https://www.wjgnet.com/2307-8960/full/v9/i3/614.htm
DOI: https://dx.doi.org/10.12998/wjcc.v9.i3.614